Phosphodiesterase 4 inhibitors
US7585882B2 · kind B2 · utility
1Cited by
15References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2005 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Oct 20, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I:wherein R1, R2, and R3 are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.